|
|
|
Insider
Information: |
Kewalramani Reshma |
Relationship: |
Director |
City: |
Boston |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
202,113 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$53,819,908 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
202,113 |
|
|
Total
Value |
$53,819,908 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
0
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
Percentage
Gain/Loss : |
23.1%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Vertex Pharmaceuticals Inc |
VRTX |
CEO & President, Direc... |
2024-05-24 |
121,374 |
2018-10-08 |
0 |
Premium* |
|
Ginkgo Bioworks Holdings, Inc |
DNA |
Director |
2022-09-30 |
80,739 |
2022-06-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
58 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
|
2021-02-17 |
4 |
D |
$211.75 |
$440,440 |
D/D |
(2,080) |
66,541 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
|
2021-02-10 |
4 |
D |
$214.16 |
$634,342 |
D/D |
(2,962) |
68,621 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
|
2021-02-24 |
4 |
D |
$217.57 |
$630,518 |
D/D |
(2,898) |
63,643 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP and CMO |
|
2019-11-25 |
4 |
AS |
$219.37 |
$1,029,284 |
D/D |
(4,692) |
13,098 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
|
2022-02-24 |
4 |
D |
$227.86 |
$1,651,074 |
D/D |
(7,246) |
122,842 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP and CMO |
|
2020-02-25 |
4 |
AS |
$229.72 |
$848,371 |
D/D |
(3,634) |
26,626 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
|
2022-02-17 |
4 |
D |
$232.51 |
$1,995,866 |
D/D |
(8,584) |
130,088 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
|
2022-02-10 |
4 |
D |
$237.74 |
$720,590 |
D/D |
(3,031) |
138,672 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP and CMO |
|
2020-02-06 |
4 |
AS |
$238.76 |
$496,600 |
D/D |
(2,074) |
35,285 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP and CMO |
|
2020-02-24 |
4 |
D |
$239.23 |
$693,289 |
D/D |
(2,898) |
30,260 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP and CMO |
|
2020-02-17 |
4 |
D |
$241.50 |
$227,976 |
D/D |
(944) |
34,341 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP and CMO |
|
2020-02-18 |
4 |
AS |
$241.71 |
$288,070 |
D/D |
(1,183) |
33,158 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
|
2020-08-06 |
4 |
AS |
$269.11 |
$562,205 |
D/D |
(2,073) |
26,626 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
|
2020-05-06 |
4 |
AS |
$270.35 |
$565,882 |
D/D |
(2,074) |
26,626 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
|
2020-05-15 |
4 |
AS |
$274.37 |
$28,132 |
D/D |
(99) |
26,626 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
|
2023-02-24 |
4 |
D |
$289.12 |
$2,713,680 |
D/D |
(9,386) |
129,969 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
|
2022-06-24 |
4 |
AS |
$291.30 |
$3,405,006 |
D/D |
(11,689) |
111,153 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
|
2023-02-17 |
4 |
D |
$292.85 |
$2,740,783 |
D/D |
(9,359) |
139,355 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
|
2023-02-10 |
4 |
D |
$294.33 |
$992,481 |
D/D |
(3,372) |
154,704 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
|
2023-02-13 |
4 |
D |
$298.26 |
$1,786,577 |
D/D |
(5,990) |
148,714 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
|
2022-08-15 |
4 |
AS |
$305.06 |
$3,565,846 |
D/D |
(11,689) |
99,598 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
|
2023-01-25 |
4 |
AS |
$315.05 |
$3,150,500 |
D/D |
(10,000) |
89,598 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
|
2023-04-27 |
4 |
AS |
$338.69 |
$1,124,726 |
D/D |
(3,317) |
126,652 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
|
2023-07-17 |
4 |
AS |
$355.00 |
$2,778,940 |
D/D |
(7,828) |
118,906 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
|
2023-11-13 |
4 |
AS |
$377.00 |
$1,921,569 |
D/D |
(5,097) |
113,809 |
0 |
% |
|
58 Records found
|
|
Page 2 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|